Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate: TrueLabor™, A New External Monitoring Device: Prospective Observational Study

NCT05782296 is registered in ClinicalTrials.gov with OB-Tools Ltd. as lead sponsor.

NCT NCT05782296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05782296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate: TrueLabor™, A New External Monitoring Device: Prospective Observational Study
Lead sponsor
OB-Tools Ltd.
Phase
Observational
Overall status
Completed
Start date
February 24, 2022
Completion date
June 5, 2024
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fetal heart rate or rhythm abnormality affecting newborn during labor, obstetric complication, uterine contractions